T4 RNA Ligase 1

Product Inquiry

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
ItolizumabT-1-hT; EQ-001; T-1-h; h-T1; Bmab-600ApprovedBiocon Ltd, Center Of Molecular Immunology, Biotech Pharmaceuticals Co LtdAlzumabIndiaPlaque psoriasisBiocon Ltd2013-01-01Dermatomyositis; Graft vs Host Disease; Lupus Erythematosus, Cutaneous; Coronavirus Disease 2019 (COVID-19); Lupus Nephritis; Respiratory Distress Syndrome, Adult; Psoriasis; Asthma; Plaque psoriasis
Details
  • Product Inquiry
  • Marketed Drug Information
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호